Quarry LP Recursion Pharmaceuticals, Inc. Transaction History

Quarry LP

$470 Billion
Q2 2025

A detailed history of Quarry LP transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Quarry LP holds 1,646 shares of RXRX stock, worth $9,036. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,646

Holding current value

$9,036

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2025 Aug 14, 2025	BUY	$3.97 - $5.84 $6,534 - $9,612	1,646 New	1,646 $8.33 Million
Q2 2024 Aug 14, 2024	BUY	$7.35 - $10.05 $1,014 - $1,386	138 New	138 $1.04 Million

Others Institutions Holding RXRX

# of Institutions

367

Shares Held

288M

Call Options Held

7.76M

Put Options Held

6.19M

Vanguard Group Inc Valley Forge, PA

36.1M
Shares

$198 Million
0.0% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

33M
Shares

$181 Million
1.38% of portfolio
Baillie Gifford & CO

24.2M
Shares

$133 Million
0.1% of portfolio
Black Rock Inc. New York, NY

17.3M
Shares

$95 Million
0.0% of portfolio
Softbank Group Corp Minato Ku Tokyo, M0

14.7M
Shares

$80.5 Million
0.31% of portfolio

View Full List

About RECURSION PHARMACEUTICALS, INC.

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $991M
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

More about RXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quarry LP, based on Form 13F filings with the SEC.

News

Stay updated on Quarry LP with notifications on news.

Account